Global Long-acting Injectable Medications Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Long-acting Injectable Medications Market Size 2017-2028

2.1.2 Long-acting Injectable Medications Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Long-acting Injectable Medications Segment by Type

2.2.1 First-generation

2.2.2 Second-generation

2.3 Long-acting Injectable Medications Market Size by Type

2.3.1 Long-acting Injectable Medications Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Long-acting Injectable Medications Market Size Market Share by Type (2017-2022)

2.4 Long-acting Injectable Medications Segment by Application

2.4.1 Schizophrenia

2.4.2 Contraception

2.4.3 HIV

2.4.4 Others

2.5 Long-acting Injectable Medications Market Size by Application

2.5.1 Long-acting Injectable Medications Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Long-acting Injectable Medications Market Size Market Share by Application (2017-2022)

3 Long-acting Injectable Medications Market Size by Player

3.1 Long-acting Injectable Medications Market Size Market Share by Players

3.1.1 Global Long-acting Injectable Medications Revenue by Players (2020-2022)

3.1.2 Global Long-acting Injectable Medications Revenue Market Share by Players (2020-2022)

3.2 Global Long-acting Injectable Medications Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Long-acting Injectable Medications by Regions

4.1 Long-acting Injectable Medications Market Size by Regions (2017-2022)

4.2 Americas Long-acting Injectable Medications Market Size Growth (2017-2022)

4.3 APAC Long-acting Injectable Medications Market Size Growth (2017-2022)

4.4 Europe Long-acting Injectable Medications Market Size Growth (2017-2022)

4.5 Middle East & Africa Long-acting Injectable Medications Market Size Growth (2017-2022)

5 Americas

5.1 Americas Long-acting Injectable Medications Market Size by Country (2017-2022)

5.2 Americas Long-acting Injectable Medications Market Size by Type (2017-2022)

5.3 Americas Long-acting Injectable Medications Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Long-acting Injectable Medications Market Size by Region (2017-2022)

6.2 APAC Long-acting Injectable Medications Market Size by Type (2017-2022)

6.3 APAC Long-acting Injectable Medications Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Long-acting Injectable Medications by Country (2017-2022)

7.2 Europe Long-acting Injectable Medications Market Size by Type (2017-2022)

7.3 Europe Long-acting Injectable Medications Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Long-acting Injectable Medications by Region (2017-2022)

8.2 Middle East & Africa Long-acting Injectable Medications Market Size by Type (2017-2022)

8.3 Middle East & Africa Long-acting Injectable Medications Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Long-acting Injectable Medications Market Forecast

10.1 Global Long-acting Injectable Medications Forecast by Regions (2023-2028)

10.1.1 Global Long-acting Injectable Medications Forecast by Regions (2023-2028)

10.1.2 Americas Long-acting Injectable Medications Forecast

10.1.3 APAC Long-acting Injectable Medications Forecast

10.1.4 Europe Long-acting Injectable Medications Forecast

10.1.5 Middle East & Africa Long-acting Injectable Medications Forecast

10.2 Americas Long-acting Injectable Medications Forecast by Country (2023-2028)

10.2.1 United States Long-acting Injectable Medications Market Forecast

10.2.2 Canada Long-acting Injectable Medications Market Forecast

10.2.3 Mexico Long-acting Injectable Medications Market Forecast

10.2.4 Brazil Long-acting Injectable Medications Market Forecast

10.3 APAC Long-acting Injectable Medications Forecast by Region (2023-2028)

10.3.1 China Long-acting Injectable Medications Market Forecast

10.3.2 Japan Long-acting Injectable Medications Market Forecast

10.3.3 Korea Long-acting Injectable Medications Market Forecast

10.3.4 Southeast Asia Long-acting Injectable Medications Market Forecast

10.3.5 India Long-acting Injectable Medications Market Forecast

10.3.6 Australia Long-acting Injectable Medications Market Forecast

10.4 Europe Long-acting Injectable Medications Forecast by Country (2023-2028)

10.4.1 Germany Long-acting Injectable Medications Market Forecast

10.4.2 France Long-acting Injectable Medications Market Forecast

10.4.3 UK Long-acting Injectable Medications Market Forecast

10.4.4 Italy Long-acting Injectable Medications Market Forecast

10.4.5 Russia Long-acting Injectable Medications Market Forecast

10.5 Middle East & Africa Long-acting Injectable Medications Forecast by Region (2023-2028)

10.5.1 Egypt Long-acting Injectable Medications Market Forecast

10.5.2 South Africa Long-acting Injectable Medications Market Forecast

10.5.3 Israel Long-acting Injectable Medications Market Forecast

10.5.4 Turkey Long-acting Injectable Medications Market Forecast

10.5.5 GCC Countries Long-acting Injectable Medications Market Forecast

10.6 Global Long-acting Injectable Medications Forecast by Type (2023-2028)

10.7 Global Long-acting Injectable Medications Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Eli Lilly

11.1.1 Eli Lilly Company Information

11.1.2 Eli Lilly Long-acting Injectable Medications Product Offered

11.1.3 Eli Lilly Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Eli Lilly Main Business Overview

11.1.5 Eli Lilly Latest Developments

11.2 Alkermes

11.2.1 Alkermes Company Information

11.2.2 Alkermes Long-acting Injectable Medications Product Offered

11.2.3 Alkermes Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Alkermes Main Business Overview

11.2.5 Alkermes Latest Developments

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Information

11.3.2 Johnson & Johnson Long-acting Injectable Medications Product Offered

11.3.3 Johnson & Johnson Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Johnson & Johnson Main Business Overview

11.3.5 Johnson & Johnson Latest Developments

11.4 Zogenix

11.4.1 Zogenix Company Information

11.4.2 Zogenix Long-acting Injectable Medications Product Offered

11.4.3 Zogenix Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Zogenix Main Business Overview

11.4.5 Zogenix Latest Developments

11.5 DURECT

11.5.1 DURECT Company Information

11.5.2 DURECT Long-acting Injectable Medications Product Offered

11.5.3 DURECT Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 DURECT Main Business Overview

11.5.5 DURECT Latest Developments

11.6 Mapi Pharma

11.6.1 Mapi Pharma Company Information

11.6.2 Mapi Pharma Long-acting Injectable Medications Product Offered

11.6.3 Mapi Pharma Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Mapi Pharma Main Business Overview

11.6.5 Mapi Pharma Latest Developments

11.7 GSK

11.7.1 GSK Company Information

11.7.2 GSK Long-acting Injectable Medications Product Offered

11.7.3 GSK Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 GSK Main Business Overview

11.7.5 GSK Latest Developments

11.8 MedinCell

11.8.1 MedinCell Company Information

11.8.2 MedinCell Long-acting Injectable Medications Product Offered

11.8.3 MedinCell Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 MedinCell Main Business Overview

11.8.5 MedinCell Latest Developments

11.9 Oakwood Labs

11.9.1 Oakwood Labs Company Information

11.9.2 Oakwood Labs Long-acting Injectable Medications Product Offered

11.9.3 Oakwood Labs Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Oakwood Labs Main Business Overview

11.9.5 Oakwood Labs Latest Developments

11.10 Nanomi

11.10.1 Nanomi Company Information

11.10.2 Nanomi Long-acting Injectable Medications Product Offered

11.10.3 Nanomi Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Nanomi Main Business Overview

11.10.5 Nanomi Latest Developments

11.11 Pharmathen

11.11.1 Pharmathen Company Information

11.11.2 Pharmathen Long-acting Injectable Medications Product Offered

11.11.3 Pharmathen Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Pharmathen Main Business Overview

11.11.5 Pharmathen Latest Developments

11.12 Kashiv BioSciences

11.12.1 Kashiv BioSciences Company Information

11.12.2 Kashiv BioSciences Long-acting Injectable Medications Product Offered

11.12.3 Kashiv BioSciences Long-acting Injectable Medications Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Kashiv BioSciences Main Business Overview

11.12.5 Kashiv BioSciences Latest Developments

12 Research Findings and Conclusion

Table 1. Long-acting Injectable Medications Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of First-generation

Table 3. Major Players of Second-generation

Table 4. Long-acting Injectable Medications Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Long-acting Injectable Medications Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Long-acting Injectable Medications Market Size Market Share by Type (2017-2022)

Table 7. Long-acting Injectable Medications Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Long-acting Injectable Medications Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Long-acting Injectable Medications Market Size Market Share by Application (2017-2022)

Table 10. Global Long-acting Injectable Medications Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Long-acting Injectable Medications Revenue Market Share by Player (2020-2022)

Table 12. Long-acting Injectable Medications Key Players Head office and Products Offered

Table 13. Long-acting Injectable Medications Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Long-acting Injectable Medications Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Long-acting Injectable Medications Market Size Market Share by Regions (2017-2022)

Table 18. Americas Long-acting Injectable Medications Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Long-acting Injectable Medications Market Size Market Share by Country (2017-2022)

Table 20. Americas Long-acting Injectable Medications Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Long-acting Injectable Medications Market Size Market Share by Type (2017-2022)

Table 22. Americas Long-acting Injectable Medications Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Long-acting Injectable Medications Market Size Market Share by Application (2017-2022)

Table 24. APAC Long-acting Injectable Medications Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Long-acting Injectable Medications Market Size Market Share by Region (2017-2022)

Table 26. APAC Long-acting Injectable Medications Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Long-acting Injectable Medications Market Size Market Share by Type (2017-2022)

Table 28. APAC Long-acting Injectable Medications Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Long-acting Injectable Medications Market Size Market Share by Application (2017-2022)

Table 30. Europe Long-acting Injectable Medications Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Long-acting Injectable Medications Market Size Market Share by Country (2017-2022)

Table 32. Europe Long-acting Injectable Medications Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Long-acting Injectable Medications Market Size Market Share by Type (2017-2022)

Table 34. Europe Long-acting Injectable Medications Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Long-acting Injectable Medications Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Long-acting Injectable Medications Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Long-acting Injectable Medications Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Long-acting Injectable Medications Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Long-acting Injectable Medications Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Long-acting Injectable Medications Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Long-acting Injectable Medications Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Long-acting Injectable Medications

Table 43. Key Market Challenges & Risks of Long-acting Injectable Medications

Table 44. Key Industry Trends of Long-acting Injectable Medications

Table 45. Global Long-acting Injectable Medications Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Long-acting Injectable Medications Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Long-acting Injectable Medications Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Long-acting Injectable Medications Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Long-acting Injectable Medications Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Long-acting Injectable Medications Market Size Market Share Forecast by Application (2023-2028)

Table 51. Eli Lilly Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 52. Eli Lilly Long-acting Injectable Medications Product Offered

Table 53. Eli Lilly Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Eli Lilly Main Business

Table 55. Eli Lilly Latest Developments

Table 56. Alkermes Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 57. Alkermes Long-acting Injectable Medications Product Offered

Table 58. Alkermes Main Business

Table 59. Alkermes Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Alkermes Latest Developments

Table 61. Johnson & Johnson Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 62. Johnson & Johnson Long-acting Injectable Medications Product Offered

Table 63. Johnson & Johnson Main Business

Table 64. Johnson & Johnson Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Johnson & Johnson Latest Developments

Table 66. Zogenix Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 67. Zogenix Long-acting Injectable Medications Product Offered

Table 68. Zogenix Main Business

Table 69. Zogenix Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Zogenix Latest Developments

Table 71. DURECT Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 72. DURECT Long-acting Injectable Medications Product Offered

Table 73. DURECT Main Business

Table 74. DURECT Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. DURECT Latest Developments

Table 76. Mapi Pharma Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 77. Mapi Pharma Long-acting Injectable Medications Product Offered

Table 78. Mapi Pharma Main Business

Table 79. Mapi Pharma Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Mapi Pharma Latest Developments

Table 81. GSK Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 82. GSK Long-acting Injectable Medications Product Offered

Table 83. GSK Main Business

Table 84. GSK Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. GSK Latest Developments

Table 86. MedinCell Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 87. MedinCell Long-acting Injectable Medications Product Offered

Table 88. MedinCell Main Business

Table 89. MedinCell Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. MedinCell Latest Developments

Table 91. Oakwood Labs Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 92. Oakwood Labs Long-acting Injectable Medications Product Offered

Table 93. Oakwood Labs Main Business

Table 94. Oakwood Labs Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Oakwood Labs Latest Developments

Table 96. Nanomi Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 97. Nanomi Long-acting Injectable Medications Product Offered

Table 98. Nanomi Main Business

Table 99. Nanomi Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Nanomi Latest Developments

Table 101. Pharmathen Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 102. Pharmathen Long-acting Injectable Medications Product Offered

Table 103. Pharmathen Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Pharmathen Main Business

Table 105. Pharmathen Latest Developments

Table 106. Kashiv BioSciences Details, Company Type, Long-acting Injectable Medications Area Served and Its Competitors

Table 107. Kashiv BioSciences Long-acting Injectable Medications Product Offered

Table 108. Kashiv BioSciences Main Business

Table 109. Kashiv BioSciences Long-acting Injectable Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Kashiv BioSciences Latest Developments

List of Figures

Figure 1. Long-acting Injectable Medications Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Long-acting Injectable Medications Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Long-acting Injectable Medications Market Size Market Share by Type in 2021

Figure 7. Long-acting Injectable Medications in Schizophrenia

Figure 8. Global Long-acting Injectable Medications Market: Schizophrenia (2017-2022) & ($ Millions)

Figure 9. Long-acting Injectable Medications in Contraception

Figure 10. Global Long-acting Injectable Medications Market: Contraception (2017-2022) & ($ Millions)

Figure 11. Long-acting Injectable Medications in HIV

Figure 12. Global Long-acting Injectable Medications Market: HIV (2017-2022) & ($ Millions)

Figure 13. Long-acting Injectable Medications in Others

Figure 14. Global Long-acting Injectable Medications Market: Others (2017-2022) & ($ Millions)

Figure 15. Global Long-acting Injectable Medications Market Size Market Share by Application in 2021

Figure 16. Global Long-acting Injectable Medications Revenue Market Share by Player in 2021

Figure 17. Global Long-acting Injectable Medications Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Long-acting Injectable Medications Market Size 2017-2022 ($ Millions)

Figure 19. APAC Long-acting Injectable Medications Market Size 2017-2022 ($ Millions)

Figure 20. Europe Long-acting Injectable Medications Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Long-acting Injectable Medications Market Size 2017-2022 ($ Millions)

Figure 22. Americas Long-acting Injectable Medications Value Market Share by Country in 2021

Figure 23. Americas Long-acting Injectable Medications Consumption Market Share by Type in 2021

Figure 24. Americas Long-acting Injectable Medications Market Size Market Share by Application in 2021

Figure 25. United States Long-acting Injectable Medications Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Long-acting Injectable Medications Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Long-acting Injectable Medications Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Long-acting Injectable Medications Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Long-acting Injectable Medications Market Size Market Share by Region in 2021

Figure 30. APAC Long-acting Injectable Medications Market Size Market Share by Application in 2021

Figure 31. China Long-acting Injectable Medications Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Long-acting Injectable Medications Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Long-acting Injectable Medications Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Long-acting Injectable Medications Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Long-acting Injectable Medications Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Long-acting Injectable Medications Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Long-acting Injectable Medications Market Size Market Share by Country in 2021

Figure 38. Europe Long-acting Injectable Medications Market Size Market Share by Type in 2021

Figure 39. Europe Long-acting Injectable Medications Market Size Market Share by Application in 2021

Figure 40. Germany Long-acting Injectable Medications Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Long-acting Injectable Medications Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Long-acting Injectable Medications Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Long-acting Injectable Medications Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Long-acting Injectable Medications Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Long-acting Injectable Medications Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Long-acting Injectable Medications Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Long-acting Injectable Medications Market Size Market Share by Application in 2021

Figure 48. Egypt Long-acting Injectable Medications Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Long-acting Injectable Medications Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Long-acting Injectable Medications Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Long-acting Injectable Medications Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Long-acting Injectable Medications Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 54. APAC Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 55. Europe Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 57. United States Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 58. Canada Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 61. China Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 62. Japan Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 63. Korea Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 65. India Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 66. Australia Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 67. Germany Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 68. France Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 69. UK Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 70. Italy Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 71. Russia Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 72. Spain Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 75. Israel Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Long-acting Injectable Medications Market Size 2023-2028 ($ Millions)